Skip to content
Disclosery

HealthCor Management, L.P.

Follow

13F filer, CIK 1343781, NEW YORK, NY

HealthCor Management, L.P. reported $109,111,527 across 22 holdings for the quarter ended 2022-12-31, in a 13F-HR filed 2023-02-15. Its ten largest share positions make up 91.26% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001343781-23-000001

Period
2022-12-31
Reported value
$109M
Holdings
22
Top 10 weight
91.26%
New
6
Sold out
43

Largest buys vs the previous quarter

SecurityShares changeApprox. value
DXCMadded+67,880$7.69M
ACRVnew+284,201$3.27M
CNMDnew+27,500$2.44M
ISRGnew+5,750$1.53M
PENnew+5,000$1.11M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ABBVexited-310,250-$41.6M
Aexited-338,030-$41.1M
BMRNreduced-391,273-$40.5M
BSXexited-958,600-$37.1M
LLYexited-103,150-$33.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2022

Share positions as resolved from 13F-HR 0001343781-23-000001, largest first. % of portfolio is the value over $109,111,523, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: 227,450 shares; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 159,320 shares; 2022Q1: 769,016 shares; 2022Q2: 740,948 shares; 2022Q3: 759,038 shares; 2022Q4: 367,765 shares 367,765$38.1M34.88%-391,273Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: 142,110 shares; 2021Q2: 50,890 shares; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: 74,780 shares; 2022Q3: 253,500 shares; 2022Q4: 321,380 shares 321,380$36.4M33.35%+67,880Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: 462,500 shares; 2021Q2: 749,310 shares; 2021Q3: 434,500 shares; 2021Q4: 94,120 shares; 2022Q1: 1,135,110 shares; 2022Q2: 485,600 shares; 2022Q3: 434,560 shares; 2022Q4: 164,440 shares 164,440$7.53M6.91%-270,120Timeline
ACRVACRIVON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 284,201 shares 284,201$3.27M3%newTimeline
HYPRHYPERFINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 691,650 shares; 2022Q1: 1,750,000 shares; 2022Q2: 2,749,400 shares; 2022Q3: 2,749,400 shares; 2022Q4: 3,880,900 shares 3,880,900$3.26M2.99%+1,131,500Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: 140,630 shares; 2022Q2: not reported; 2022Q3: 303,500 shares; 2022Q4: 110,000 shares 110,000$2.87M2.63%-193,500Timeline
CNMDCONMED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: 276,940 shares; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 27,500 shares 27,500$2.44M2.23%newTimeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: 389,980 shares; 2021Q3: 445,739 shares; 2021Q4: 365,737 shares; 2022Q1: 23,480 shares; 2022Q2: not reported; 2022Q3: 21,720 shares; 2022Q4: 20,000 shares 20,000$2.39M2.19%-1,720Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: 1,371,480 shares; 2021Q2: 1,751,342 shares; 2021Q3: 1,214,670 shares; 2021Q4: 1,157,560 shares; 2022Q1: 1,180,500 shares; 2022Q2: 923,400 shares; 2022Q3: 859,240 shares; 2022Q4: 70,000 shares 70,000$1.78M1.63%-789,240Timeline
CHINOOK THERAPEUTICS INCCHINOOK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 266,830 shares; 2022Q4: 60,000 shares 60,000$1.57M1.44%-206,830
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: 72,490 shares; 2022Q3: not reported; 2022Q4: 5,750 shares 5,750$1.53M1.4%newTimeline
BLUEPRINT MEDICINES CORPBLUEPRINT MEDICINES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 104,600 shares; 2022Q4: 30,000 shares 30,000$1.31M1.2%-74,600
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: 900,000 shares; 2022Q2: 1,000,000 shares; 2022Q3: 1,904,234 shares; 2022Q4: 500,000 shares 500,000$1.21M1.11%-1,404,234Timeline
PENPENUMBRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 5,000 shares 5,000$1.11M1.02%newTimeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 445,140 shares; 2022Q4: 50,000 shares 50,000$978K0.9%-395,140Timeline
RAIN ONCOLOGY INCRAIN ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 120,000 shares 120,000$960K0.88%new
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 17,490 shares; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 38,240 shares; 2022Q4: 3,500 shares 3,500$882K0.81%-34,740Timeline
SILK ROAD MEDICAL INCSILK ROAD MEDICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 15,000 shares 15,000$793K0.73%new
IMMUNOGEN INCIMMUNOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 200,000 shares; 2021Q4: 1,310,340 shares; 2022Q1: 1,310,340 shares; 2022Q2: 500,000 shares; 2022Q3: 1,300,000 shares; 2022Q4: 150,000 shares 150,000$744K0.68%-1,150,000
EQRX INCEQRX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 99,998 shares; 2022Q1: 99,998 shares; 2022Q2: 99,998 shares; 2022Q3: 35,239 shares; 2022Q4: 35,239 shares 35,239$9.45K0.01%0
EUCRATES BIOMEDICAL ACQU COREUCRATES BIOMEDICAL ACQU CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 78,059 shares; 2022Q1: 78,059 shares; 2022Q2: 78,059 shares; 2022Q3: 78,059 shares; 2022Q4: 78,059 shares 78,059$4.34K<0.01%0
MEDICUS SCIENCES ACQUISITIONMEDICUS SCIENCES ACQUISITIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: not reported; 2021Q2: 82,663 shares; 2021Q3: 82,663 shares; 2021Q4: 82,663 shares; 2022Q1: 82,663 shares; 2022Q2: 82,663 shares; 2022Q3: 29,776 shares; 2022Q4: 29,776 shares 29,776$2.68K<0.01%0

Sold out in Q4 2022

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ABBVABBVIE INC310,250$41.6Mshares
AAGILENT TECHNOLOGIES INC338,030$41.1Mshares
BSXBOSTON SCIENTIFIC CORP958,600$37.1Mshares
LLYELI LILLY & CO103,150$33.4Mshares
CORCENCORA INC239,150$32.4Mshares
UNHUNITEDHEALTH GROUP INC62,980$31.8Mshares
DHRDANAHER CORP DEL117,800$30.4Mshares
THCTENET HEALTHCARE CORP518,990$26.8Mshares
TMOTHERMO FISHER SCIENTIFIC INC51,240$26Mshares
CNCCENTENE CORP DEL300,970$23.4Mshares
CITHE CIGNA GROUP76,910$21.3Mshares
HUMHUMANA INC42,920$20.8Mshares
BIIBBIOGEN INC69,950$18.7Mshares
ELVELEVANCE HEALTH INC FORMERLY38,910$17.7Mshares
AMGNAMGEN INC75,370$17Mshares
LIVNLIVANOVA PLC328,030$16.7Mshares
HSICSCHEIN HENRY INC248,920$16.4Mshares
BMYBRISTOL-MYERS SQUIBB CO223,150$15.9Mshares
INCYINCYTE CORP227,851$15.2Mshares
HORIZON THERAPEUTICS PLCHORIZON THERAPEUTICS PLC229,530$14.2Mshares
BDXBECTON DICKINSON & CO62,930$14Mshares
KEZAR LIFE SCIENCES INCKEZAR LIFE SCIENCES INC1,607,650$13.8Mshares
CVSCVS HEALTH CORP131,150$12.5Mshares
MCKMCKESSON CORP35,040$11.9Mshares
ABTABBOTT LABORATORIES98,970$9.58Mshares
MOHMOLINA HEALTHCARE INC27,540$9.08Mshares
HOLXHOLOGIC INC137,330$8.86Mshares
SEAGEN INCSEAGEN INC57,340$7.85Mshares
SHOCKWAVE MED INCSHOCKWAVE MED INC19,720$5.48Mshares
MERUS N VMERUS N V272,890$5.47Mshares
XRAYDENTSPLY SIRONA INC158,200$4.49Mshares
AFFIMED N VAFFIMED N V1,721,925$3.55Mshares
CANO HEALTH INCCANO HEALTH INC395,560$3.43Mshares
NEONEOGENOMICS INC391,110$3.37Mshares
NEVRO CORPNEVRO CORP67,600$3.15Mshares
BLUEBIRD BIO INCBLUEBIRD BIO INC455,000$2.88Mshares
NTRANATERA INC65,130$2.85Mshares
REVANCE THERAPEUTICS INCREVANCE THERAPEUTICS INC64,590$1.74Mshares
IVERIC BIO INCIVERIC BIO INC85,230$1.53Mshares
LEAP THERAPEUTICS INCLEAP THERAPEUTICS INC1,066,689$939Kshares
IKENA ONCOLOGY INCIKENA ONCOLOGY INC220,082$781Kshares
LONGVIEW ACQUISITION CORP IILONGVIEW ACQUISITION CORP II149,999$10Kshares
ORION ACQUISITION CORPORION ACQUISITION CORP50,105$0shares

How Q4 2022 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001343781-23-000001 base2023-02-15acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001343781-23-000001 Quarter ended 2022-12-312023-02-15acceptance time not in the bulk data set
13F-HR 0001343781-22-000007 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001343781-22-000004 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001343781-22-000003 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001343781-22-000001 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001343781-21-000007 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001343781-21-000006 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001343781-21-000004 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0001343781-21-000002 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR 0001343781-20-000008 Quarter ended 2020-09-302020-11-16acceptance time not in the bulk data set
13F-HR 0001343781-20-000006 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-HR 0001343781-20-000004 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-HR 0001343781-20-000002 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-HR 0001343781-19-000011 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001343781-19-000009 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR 0001343781-19-000007 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR/A 0001343781-19-000005 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR 0001343781-19-000004 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR 0001343781-18-000008 Quarter ended 2018-09-302018-11-15acceptance time not in the bulk data set
13F-HR 0001343781-18-000006 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR 0001343781-18-000004 Quarter ended 2018-03-312018-05-15acceptance time not in the bulk data set
13F-HR 0001343781-18-000002 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set
13F-HR 0001343781-17-000008 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-HR 0001343781-17-000006 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-HR 0001343781-17-000004 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-HR 0001343781-17-000002 Quarter ended 2016-12-312017-02-14acceptance time not in the bulk data set
13F-HR 0001343781-16-000016 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0001343781-16-000014 Quarter ended 2016-06-302016-08-15acceptance time not in the bulk data set
13F-HR 0001343781-16-000012 Quarter ended 2016-03-312016-05-16acceptance time not in the bulk data set
13F-HR 0001343781-16-000010 Quarter ended 2015-12-312016-02-16acceptance time not in the bulk data set
13F-HR 0001343781-15-000008 Quarter ended 2015-09-302015-11-16acceptance time not in the bulk data set
13F-HR 0001343781-15-000006 Quarter ended 2015-06-302015-08-14acceptance time not in the bulk data set
13F-HR 0001343781-15-000004 Quarter ended 2015-03-312015-05-15acceptance time not in the bulk data set
13F-HR 0001343781-15-000002 Quarter ended 2014-12-312015-02-17acceptance time not in the bulk data set
13F-HR 0001343781-14-000008 Quarter ended 2014-09-302014-11-14acceptance time not in the bulk data set
13F-HR 0001343781-14-000006 Quarter ended 2014-06-302014-08-14acceptance time not in the bulk data set
13F-HR 0001343781-14-000004 Quarter ended 2014-03-312014-05-15acceptance time not in the bulk data set
13F-HR 0001343781-14-000002 Quarter ended 2013-12-312014-02-14acceptance time not in the bulk data set
13F-HR 0001343781-13-000007 Quarter ended 2013-09-302013-11-14acceptance time not in the bulk data set
13F-HR 0001343781-13-000005 Quarter ended 2013-06-302013-08-14acceptance time not in the bulk data set